PTX 7.32% 4.4¢ prescient therapeutics limited

PTX chart, page-491

  1. 1,559 Posts.
    lightbulb Created with Sketch. 87
    also spoke to him about the car t trials and he said it will be a game changer in a few years when it rolls out as a treatment for solid tumours , already have good results with non solid Tumours
    I have also been placed on an immunotherapy named nivolumab that programs your T cells to recognise cancers that are normally invisible to the immune system , funnily enough for carcinoma it only has a 20 percent response rate , so it seems in an unmet market 20 percent response rate is good enough for big pharma to pick up imo
    none of this is investment advise just a few things I found interesting
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.003(7.32%)
Mkt cap ! $35.43M
Open High Low Value Volume
4.1¢ 4.4¢ 4.0¢ $20.95K 507.0K

Buyers (Bids)

No. Vol. Price($)
8 216927 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 238807 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.